Business Investments

Jason Hope´s Insight on Longevity

Jason Hope is a great investor, philanthropist, and entrepreneur. He also focuses on progressive medical involvement, technological advancement, and community intervention. He was born and raised in Tempe.Hope attended ASU and graduated with a degree in finance. He received an MBA from the W.P. Carey School of Business. Additionally, he is ardent about technology and giving back to society.

 

 Career 

 

After completing his studies, activist investor Jason Hope created a mobile communications firm. He is currently creating grant projects for small businesses and venturing into start-ups. Jason’s avid philanthropist passion goes deep into scientific operations, such as longevity, anti-ageing, and the human advancement niche of biomedicine.

 

 Jason’s View on Longevity and Anti-aging 

Jason Hope´s Insight on Longevity

According to research, stem cells can cure specific diseases caused by aging. However, the scientific project has yet to be exposed to the market because it needs proper research and anti aging experimentation. Stem cell research has enhanced the union between technology and medicine, technological advancements, and global connectivity worldwide; according to Jason Hope, the use of stem cells is creditable.

 

But, he adds, it needs extensive research to increase the potential of developing therapies. He encourages and emphasizes the need for a long-term study to ascertain the effectiveness and safety of stem cell treatment. Jason Hope says that most current therapies target treating the disease and its symptoms rather than preventing it. Therefore, the SENS organization aims to find ways to prevent age-related diseases. 

Jason’s contributions help researchers develop preventative treatments and expand the length of people’s lives. Moreover, with the business mentor and activist investor´s help, SENS conducts numerous research activities based on stem cell Interceding. According to Jason Hope, the SENS is currently in the second stage of clinical experiments on the stem cell treatment of Parkinson’s Disease. Jason further explains that even though the experimentation procedure may be slow, it is vital to maintain positive public support.